Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Indegene Limited ( (IN:INDGN) ) has shared an update.
Indegene Limited has announced the amalgamation of its two Canadian step-down subsidiaries, Indegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc., into a single entity named Indegene Healthcare Canada Inc., effective January 1, 2026. The internal restructuring, which is a related-party transaction with no cash consideration or change in the listed entity’s shareholding pattern, consolidates projected FY25-26 revenues of CAD 1.375 million and CAD 5.4 million from the respective businesses, streamlining Indegene’s Canadian operations and aligning its medical writing, regulatory documentation, and commercialization capabilities under one corporate structure.
More about Indegene Limited
Indegene Limited operates in the life-sciences and healthcare sector, focusing on digital-first commercialization solutions. Through technology-enabled services, it supports biopharmaceutical and medical device companies in bringing therapies to market and in engaging healthcare professionals and patients. Its subsidiaries include entities providing specialized services such as medical writing and regulatory documentation for pharmaceutical and life-science industries.
Average Trading Volume: 13,005
Technical Sentiment Signal: Sell
Current Market Cap: 124.8B INR
Find detailed analytics on INDGN stock on TipRanks’ Stock Analysis page.